Top News Stories: July 13-19
FDA approves a new diet drug, Qsymia—find out how it stacks up to the other newest drug, Belviq. Plus, the possible hidden dangers of electric fans, new hope for Alzheimer’s patients, and more of this week’s top news stories:
FDA Approves Diet Drug Qsymia
The FDA has approved its second prescription weight loss drug in less than a month. Qsymia combines the stimulant phentermine and anti-seizure drug Topamax into a controlled-release drug that is taken once a day to promote weight loss in people who are obese. Read more
Electric Fans May be Risky in Extreme Heat
Switching on fans to get through the heat wave? They may be doing more harm than good by heating the body and encouraging excess sweating, which can lead to dehydration and electrolyte imbalance. Read more
Belviq, Qsymia: New Weight Loss Drugs Compared
What you need to know about the two newest prescription weight loss drugs. Read more
Treatment May Halt Alzheimer’s Progression
In a small study, Gammagard, a form of intravenous immunoglobulin used to treat immune system disorders, has been found to stabilize and prevent memory decline in people with Alzheimer’s disease for three years. Read more
You Can Hide Your Lying Eyes
Think you can tell when someone’s lying by how their eyes move around? You can’t, according to a three-part study by U.K. and Canadian researchers. Read more
Comments
Leave a comment